Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 37,178 shares at $3.20 ($119K) on 2024-09-30, disclosed to the SEC on 2024-10-02.
Open-market sale of $119k AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.20 | 18,589 | $59K | 50.0% |
| 2 | $3.20 | 18,589 | $59K | 50.0% |
| Total | $3.20 avg | 37,178 | $119K | 100% |
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |